vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
27.35
-0.02 (-0.07%)
Dec 5, 2025, 4:00 PM EST - Market closed
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $339.38 million as of December 5, 2025. Its market cap has increased by 547.68% in one year.
Market Cap
339.38M
Enterprise Value
241.24M
1-Year Change
547.68%
Ranking
Category
Stock Price
$27.35
Market Cap Chart
Since July 30, 2015, vTv Therapeutics's market cap has decreased from $357.30M to $339.38M, a decrease of -5.01%. That is a compound annual growth rate of -0.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 107.70M | 144.77% |
| Dec 31, 2024 | 44.00M | 46.18% |
| Dec 29, 2023 | 30.10M | -56.57% |
| Dec 30, 2022 | 69.30M | -22.66% |
| Dec 31, 2021 | 89.60M | -34.79% |
| Dec 31, 2020 | 137.40M | 34.97% |
| Dec 31, 2019 | 101.80M | -5.74% |
| Dec 31, 2018 | 108.00M | -45.23% |
| Dec 29, 2017 | 197.20M | 24.42% |
| Dec 30, 2016 | 158.50M | -29.08% |
| Dec 31, 2015 | 223.50M | -37.45% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 913.96B |
| Johnson & Johnson | 491.26B |
| AbbVie | 407.81B |
| UnitedHealth Group | 302.67B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 252.30B |
| Abbott Laboratories | 217.64B |